Claravis 40 MG capsule 10S

Ended Awarded Last action

Contract number
SPE2DR26FM2XZ
Awardee
Awarding agency
Obligated
$33,115

Award facts

Contract value 100% obligated
$33,115.28 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $33.1K to AmerisourceBergen Drug Corp for 10 units of Claravis 40 mg capsules, with an ultimate completion date of January 23, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent organization, Cencora, Inc. (doing business as AmerisourceBergen), holds a significant $1 billion IDC through December 2031 that serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.

Claravis (isotretinoin) is a potent prescription medication primarily used for treating severe acne, and this procurement supports the federal government's pharmaceutical supply chain for military treatment facilities and veterans' healthcare programs. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill critical medical supply needs through open competition, with contract values ranging from small transactions to substantial orders exceeding $45K. The company's consistent selection for delivery orders under its master IDC reflects its established performance in meeting DLA requirements for pharmaceutical distribution and logistics to support Department of Defense healthcare operations.

Quick answers

Who was awarded contract SPE2DR26FM2XZ?

SPE2DR26FM2XZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.

How much is contract SPE2DR26FM2XZ worth?

The government has obligated $33,115 on SPE2DR26FM2XZ.

Is contract SPE2DR26FM2XZ an order under another contract?

Yes. SPE2DR26FM2XZ is a delivery order under SPE2DR25D3501, an indefinite delivery contract.

Was contract SPE2DR26FM2XZ competed?

The extent of competition for SPE2DR26FM2XZ was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award